Biotech

Tesla, SpaceX, and xAI CEO Elon Musk at the Conservative Political Action Conference (CPAC) on February 20, 2025 in Oxon Hill, Maryland. (Photo: Andrew Harnik/Getty Images)
Newsletters

xAI sues Apple and OpenAI

By
August 26, 2025
Sam Altman, chief executive officer of OpenAI
AI

OpenAI warns that its new ChatGPT Agent has the ability to aid dangerous bioweapon development

By
July 18, 2025
Howard Dean: Slashing public health funding is a national security disaster in the making
Commentary

Howard Dean: Slashing public health funding is a national security disaster in the making

By
June 10, 2025
Elizabeth Holmes walking hand in hand with her boyfriend Billy Evans.
Tech

‘This is not Theranos 2.0′: Elizabeth Holmes’ partner is the CEO behind new blood-testing startup

By
May 12, 2025
Why federal funding for life sciences—now being slashed—is a strategic necessity for America
Commentary

Why federal funding for life sciences—now being slashed—is a strategic necessity for America

By
April 17, 2025
Illustration of a large DNA helix and a pair of tweezers holding a small DNA segment that is about to be inserted into the helix.
Tech

Exclusive: Biotech startup Profluent says it has discovered AI ‘scaling laws’ for AI models used in protein design

By
April 16, 2025
Recursion’s automated high throughput wet lab
Features

Will AI ever cure cancer? The multibillion-dollar race to bring the first AI-discovered drug to market

By
April 3, 2025
Katherine Stueland
Tech

As a kid, she raised money to cure cystic fibrosis. Now she’s the CEO of a $2.6 billion genetic testing company

By
March 31, 2025
23andMe users are being urged to delete their data. Here’s how to do it
Health

23andMe users are being urged to delete their data. Here’s how to do it

By Alexa Mikhail and Beth Greenfield
March 24, 2025
Picture of 23andMe logo outside its California headquarters.
Tech

23andMe users told to consider deleting their data by California attorney general as the company files for bankruptcy

By
March 24, 2025
This company is launching a genetic matching feature for future parents—and the CEO says ‘it has nothing to do with eugenics’ 
Life

This company is launching a genetic matching feature for future parents—and the CEO says ‘it has nothing to do with eugenics’ 

By
March 23, 2025
My son’s rare disease diagnosis spurred me to ditch Big Pharma for a biotech startup
Commentary

My son’s rare disease diagnosis spurred me to ditch Big Pharma for a biotech startup

By
March 10, 2025
Anne Wojcicki on stage at a conference
Leadership

A few years ago 23andMe was worth $6 billion. Now CEO Anne Wojcicki is trying to buy it back for $42 million

By
March 1, 2025
Scientists working in a lab
Finance

Investors are plunking billions of dollars into AI-focused biopharma companies—a more than 300% increase from 2023

By Healthcare Brew and Maia Anderson
January 31, 2025
Sam Altman in suit and tie
Health

Sam Altman-backed AI biotech announces $1 billion for its lofty goal: adding 10 years to human life span

By
January 24, 2025

Most Popular